| Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer S Garcia-Recio, G Fuster, P Fernandez-Nogueira, EM Pastor-Arroyo, ... Cancer research 73 (21), 6424-6434, 2013 | 92 | 2013 |
| Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2 C Mayordomo, S García‐Recio, E Ametller, P Fernández‐Nogueira, ... Journal of cellular physiology 227 (4), 1358-1366, 2012 | 88 | 2012 |
| Tumor Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation. P Fernandez-Nogueira, M Mancino, G Fuster, A Lopez-Plana, P Jauregui, ... Clinical Cancer Research, 2019 | 73 | 2019 |
| The new antitumor drug ABTL0812 inhibits the Akt/mTORC1 axis by upregulating tribbles-3 pseudokinase T Erazo, M Lorente, A López-Plana, P Muñoz-Guardiola, ... Clinical Cancer Research 22 (10), 2508-2519, 2016 | 73 | 2016 |
| Differential expression of neurogenes among breast cancer subtypes identifies high risk patients P Fernández-Nogueira, P Bragado, V Almendro, E Ametller, J Rios, ... Oncotarget 7 (5), 5313, 2016 | 61 | 2016 |
| Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer P Fernández-Nogueira, A Noguera-Castells, G Fuster, L Recalde-Percaz, ... Cancer letters 424, 70-83, 2018 | 44 | 2018 |
| Tumor promoting effects of CD95 signaling in chemoresistant cells E Ametller, S García-Recio, D Costamagna, C Mayordomo, ... Molecular cancer 9 (1), 161, 2010 | 31 | 2010 |
| Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis A Zubeldia-Plazaola, L Recalde-Percaz, N Moragas, M Alcaraz, X Chen, ... Breast Cancer Research 20 (1), 65, 2018 | 16 | 2018 |
| HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer P Fernandez-Nogueira, AN Castells, GF Orellana, LR Percaz, NM Garcia, ... Cancer Research 78 (13 Supplement), 5213-5213, 2018 | | 2018 |
| Understanding the microenvironment contribution to ductal carcinoma in situ transition to invasiveness in breast cancer N Moragas, L Recalde-Percaz, A Noguera-Castells, ... Cancer Research 78 (13 Supplement), 2138-2138, 2018 | | 2018 |
| Role of syntaxin-1A, a synaptic-related protein, in HER2-enriched and luminal B breast cancer progression A Noguera-Castells, L Recalde-Percaz, N Moragas, ... Cancer Research 78 (13 Supplement), 5079-5079, 2018 | | 2018 |
| Development of TRIB3 as a novel preclinical and clinical pharmacodynamic biomarker for ABTL0812. H Pérez-Montoyo, M Yeste-Velasco, S Solé-Sánchez, P Bragado, ... Journal of Clinical Oncology 36 (15_suppl), e14556-e14556, 2018 | | 2018 |
| STX1A signaling pathway characterization in different breast cancer subtypes A Noguera-Castells, L Recalde-Percaz, N Moragas, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 515-515, 2017 | | 2017 |
| HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer P Fernandez-Nogueira, A Noguera-Castells, G Fuster, L Recalde, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 512-512, 2017 | | 2017 |
| NRP2-SEMA3s-PLXNs axis regulates the dormancy state of disseminated tumour cells and metastasis progression L Recalde-Percaz, A Noguera-Castells, N Moragas, M Mancino, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 518-518, 2017 | | 2017 |
| Substance P and its receptor NK1 regulates disseminated tumour cells biology and dormancy L Recalde-Percaz, P Jauregui, P Fernandez-Nogueira, R Alonso, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 497-497, 2017 | | 2017 |
| Neuropilin 2 regulates lung disseminated tumor cell escape from dormancy and progression into metastasis PB Domingo, R Alonso, G Fuster, M Mancino, P Fernandez-Nogueira, ... Cancer Research 76 (14 Supplement), 1574-1574, 2016 | | 2016 |
| Fibroblast growth factor receptor 2-HER2 transactivation: Role of fbroblasts in the acquisition and maintenance of anti-Her2 target therapies resistance in breast cancer PF Nogueira, M Mancino, G Fuster, E Enreig, E Ametller, P Bragado, ... Cancer Research 76 (14 Supplement), 752-752, 2016 | | 2016 |
| Neuropilin 2 regulates lung disseminated tumor cells escape from dormancy and progression into metastasis P Bragado, R Alonso, M Mancino, P Fernandez-Nogueira, G Fuster, ... European Journal of Cancer 61, S76, 2016 | | 2016 |
| Abstract A34: Role of neural mediators in the regulation of tumor dormancy and disseminated tumor cells biology M Mancino, R Alonso, P Fernandez-Nogueira, G Fuster, J Aguirre-Ghiso, ... Cancer Research 76 (7 Supplement), A34-A34, 2016 | | 2016 |
